Home News To Hasten the Company’s Transformation, Cosette Pharmaceuticals Has Named Kevin Hickey Vice President of Brand Sales and Marketing

To Hasten the Company’s Transformation, Cosette Pharmaceuticals Has Named Kevin Hickey Vice President of Brand Sales and Marketing

To Hasten the Company’s Transformation, Cosette Pharmaceuticals Has Named Kevin Hickey Vice President of Brand Sales and Marketing

Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced the appointment of Kevin Hickey as Vice President, Brand Sales and Marketing, bolstering its executive leadership team.

“We are very excited to have Kevin Hickey join our team. His tremendous experience in strategy and execution of branded products will be instrumental as we integrate our eight cardio branded products through our transformative acquisition from Daiichi Sankyo and get ready for the imminent launches of several new products and lifecycle management strategies.” said Apurva Saraf, President and CEO, Cosette Pharmaceuticals.

“I am excited to join the successful team at Cosette during this pivotal moment in their portfolio transformation. The collective skillset of the Commercial Team will allow us to deliver leading growth with our existing brands, while continuing to diversify our portfolio through organic and inorganic growth initiatives,” said Kevin Hickey, Vice President, Brand Sales and Marketing, Cosette Pharmaceuticals.”

Kevin is a Commercial leader with over 17 years of experience in the pharmaceuticals industry. His experience includes product development, launch and commercialization, strategic planning & lifecycle management, commercial architecture design & execution, Payer landscapes, pricing strategies, distribution channels as well as portfolio P&L management. His last role was as SVP for the US Commercial team for Acerus Pharma where he managed the commercial team and increased product demand while improving profitability margins. He has experience with 3PL, Wholesaler and Pharmacy partners in securing product in channel and has co-led US BD activities for strategic acquisitions, co-promotions with other pharma companies and in-licensing agreements. Prior to Acerus he worked for various Pharma companies beginning with Endo where he spent 8 years in sales, product management, and marketing roles. GE Healthcare, Syneos Health and Jazz Pharma round out his experience providing additional marketing and commercial experience.


Canon India Appoints Manabu Yamazaki As New President & CEO

Canon India Pvt. Ltd., the global leader in imaging technologies, announced the appointment of Manabu Yamazaki as the new President & CEO.

Long COVID: Why This Should Matter to HR

“Long COVID” is a term used to describe the long-lasting impact that COVID-19 can have on a person, many months after they first contract it.

Third of Employers Say Remote Working Has Boosted Productivity

According to new research by the CIPD, employers have largely seen a benefit in productivity due to the shift to remote working.

US Economy Grew Robustly in First Quarter

GDP grew at a 6.4% annual rate in the quarter, leaving the economy within 1% of its peak.

Asia-Pacific Markets Broadly Lower As Investors Turn Cautious

Asia-Pacific markets struggled for gains Friday as investors turned cautious, despite a positive finish stateside in the previous session.

Latest posts